Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$5.0M
6M shares
52-week range
$0.66 – $2.39
9% from low
Sector
OPHTHALMIC GOODS
Exchange
NASDAQ
CS
Borrow rate
25.40%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $4.8K | $57.0K | $690.7K | $659.8K | $1.2M | $1.6M | $2.7M |
| Cost of revenue | $7.7K | $74.3K | $542.4K | $716.1K | $1.3M | $1.4M | $2.1M |
| Gross profit | −$2.9K | −$17.3K | $148.3K | −$56.3K | −$119.3K | $215.2K | $567.5K |
| Gross margin | -60.4% | -30.3% | 21.5% | -8.5% | -10.4% | 13.1% | 21.3% |
| R&D | $4.1K | $36.9K | $86.3K | $524.7K | $662.2K | $819.4K | $725.4M |
| Operating income | −$109.4K | −$653.0K | −$3.2M | −$5.6M | −$6.9M | −$7.9M | −$8.5M |
| EBITDA | −$109.4K | −$762.2K | −$3.2M | −$5.5M | −$6.6M | −$7.6M | −$7.5M |
| Net income | −$109.4K | −$768.2K | −$3.2M | −$5.7M | −$6.7M | −$7.8M | −$7.6M |
| Net margin | -2269.8% | -1347.8% | -469.8% | -861.2% | -578.2% | -474.6% | -285.2% |
| EPS (diluted) | -2.64 | -5.19 | -12.37 | -17.41 | -12.67 | -5.19 | -1.90 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $7M | $-1.23 | $-1.23–$-1.23 | 1 |
| 2027 | $22M | $-0.42 | $-0.42–$-0.42 | 1 |
Forward consensus · source: Financial Modeling Prep
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.
www.lucyd.coNo one on the platform currently holds LUCY.
No tracked institution reports a position in LUCY as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-07-18 | 1-for-20reverse |
No one on the platform has traded LUCY yet.
| $2M |
| — |
| CHEKCheck-Cap Ltd. | $1.86 | +1.64% | $11M | — |
| KPRXKiora Pharmaceuticals, Inc. | $2.61 | +2.76% | $12M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
New advancements in smart eyewear are helping bridge the gap between wearable technology and personalized vision care. Our client, Innovative Eyewear Inc (Nasdaq: $LUCY ; $LUCYW), has announced a partnership with Encore Optical Laboratories to expand prescription fulfillment capabilities and introduce new lens technologies across its Lucyd smart eyewear platform. The partnership enables customers to access innovative features including Chemistrie Eyewear magnetic lens clips, ZEISS Vision PhotoFusion X photochromic lenses, and expanded prescription compatibility for Lucyd Armor smart safety glasses. As smart wearable technology continues to gain momentum, partnerships like this demonstrate how innovation can improve accessibility, customization, and everyday functionality. 🔗 See what's next for Innovative Eyewear: https://www.prnewswire.com/news-releases/innovative-eyewear-inc-partners-with-encore-optical-laboratory-to-provide-new-lens-technologies-for-smart-eyewear-302806681.html?tc=eml_cleartime Skyline is paid by $LUCY for IR services. Disclaimer 17(b): http://skylineccg.com/disclosures/
View on StockTwits ↗$LUCY that consolidation did more good than harm.
View on StockTwits ↗Innovative Eyewear ($LUCY) is partnering with Encore Optical Laboratory to expand lens tech for Lucyd smart eyewear, including Chemistrie magnetic clips and Zeiss PhotoFusion X photochromic lenses. #LUCY #Lucyd #smarteyewear #wearables #optical https://prismmarketview.com/smart-glasses-go-mainstream-innovative-eyewear-expands-lens-options-with-encore-optical-deal/
View on StockTwits ↗$LUCY so far a lot of talk and bragging about business. But at the end its a disappointing stock.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Trading at 0.5× sales vs its 8.9× historical median P/S.
Fair value ≈ $14.60 · price $0.82 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.